Analyzing Pharmacare Costs and Budget Realism

Exploring the disparity between stated pharmacare costs and actual drug expenditures, focusing on the financial burden on public and private insurance systems, out-of-pocket expenses, and the substantial costs related to diabetes medications. The chapter questions the feasibility of the 1.5 billion budget estimate, emphasizing the call for transparency and a sustainable financing strategy.